Results 81 to 90 of about 373,840 (223)
Acta Gastroenterológica Latinoamericana, 2009 Introducción. El tratamiento recomendado para los pacientes con hepatitis B crónica HBeAg positivo es PEG interferón alfa 2a durante 48 semanas. No hay suficientes datos que avalen mejor respuesta con 48 semanas de tratamiento versus 24 semanas.
Joaquín Solari +9 more
doaj
Annals of Hepatology, 2010 There are no well established treatment guidelines about acute hepatitis C (AHC), leaving physicians to make several challenging decisions, such whether to treat, when to treat and what treatment regimens to use.
Paulo Roberto Lerias de Almeida
doaj +1 more source
Nanoparticle‐Mediated Therapy for Glioma: Advances and Prospects
MedComm – Oncology, Volume 5, Issue 3, September 2026.Various nanocarriers, including liposomes, dendrimers, exosomes and gold nanoparticles, are designed to penetrate the blood‐brain barrier and deliver chemotherapy, radiotherapy, immunotherapy, gene therapy, phototherapy, magnetic hyperthermia and sonodynamic therapy for glioma.
Wenqian Jiang +5 more
wiley +1 more source
Annals of Hepatology, 2012 Introduction. A large number of patients with chronic hepatitis C have not been cured with interferon-based therapy. Therefore, we evaluated the efficacy of amantadine combined with the standard of care (pegylated interferon plus ribavirin) in patients ...
Mario G. Pessôa +12 more
doaj +1 more source
Anemia of Inflammation in Solid Tumor Patients and Practical Education for Oncologists and Nurses
Thoracic Cancer, Volume 17, Issue 17, September 2026.Tumor‐ and immune‐derived cytokines including IL‐6, IL‐1β, TNF‐α, TGF‐β, IL‐10, and IFN‐γ drive anemia of inflammation: IL‐6/TNF‐α upregulate hepatic hepcidin to block iron export, while other cytokines suppress erythropoiesis and shorten red cell survival.
Xiaoyan Si +5 more
wiley +1 more source
Journal of Infection in Developing Countries, 2011 Interferon alpha is a molecule frequently used in the treatment of chronic hepatitis B, C, and D, with immunomodulatory and antiviral activity. It is also used in some cancer types. It has been widely claimed that interferon alpha triggers autoimmunity,
Sukran Kose +3 more
doaj +1 more source
Characterising Hepatitis D Virus in the UK From 2011 to 2021
Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.ABSTRACT Little is known about hepatitis B virus (HBV) and Hepatitis D virus (HDV) coinfection in the UK. HDV screening is recommended among all individuals with HBV, with coinfection associated with increased disease progression. Using data on HDV testing, shared by 11 laboratories in the UK who reported undertaking HDV testing, and national testing ...
R. Simmons +67 more
wiley +1 more source
Liver International, Volume 46, Issue 9, September 2026.ABSTRACT Background & Aims Prognostic non‐invasive tests for liver‐related events in compensated cirrhosis are needed. Endotrophin, a fragment of type VI alpha 3 collagen involved in fibrosis and inflammation, has been associated with adverse outcomes in several chronic diseases.
Thomas Wiggers +7 more
wiley +1 more source
PLoS ONE, 2014 BackgroundIL28B gene polymorphism is the best baseline predictor of response to interferon alfa-based antiviral therapies in chronic hepatitis C. Recently, a new IFN-L4 polymorphism was identified as first potential functional variant for induction of ...
Simone Susser +8 more
doaj +1 more source
Hepatology, 2014 There is little information on the early kinetics of hepatitis delta virus (HDV) and hepatitis B surface antigen (HBsAg) during interferon‐α therapy.
J. Guedj +10 more
semanticscholar +1 more source